Suzuki Y - Mount Sinai School of Medicine
Mesothelioma Cancer Expert at Mount Sinai School of Medicine, New York, NY
Mesothelioma Cancer Expert - Suzuki Y - Current Listing of Published Papers
The following is a listing of research papers by Suzuki Y in the field of mesothelioma cancer.
| Suzuki Y, Yuen SR, Ashley R. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health. 2005;208(3):201-10. Pubmed 15971859 Department of Community and Preventive Medicine, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1057, New York, NY 10029, USA. [mssm.edu] |
| Landrigan PJ, Nicholson WJ, Suzuki Y, Ladou J. The hazards of chrysotile asbestos: a critical review. Ind Health. 1999 Jul;37(3):271-80. Pubmed 10441898 Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, N.Y. 10029, USA. |
| Kindler HL, Millard F, Herndon JE 2nd, Vogelzang NJ, Suzuki Y, Green MR. Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B. Lung Cancer. 2001 Feb-Mar;31(2-3):311-7. Pubmed 11165412 University of Chicago Medical Center, 5841 S. Maryland Avenue, Chicago, IL 60637, USA. [medicine.bsd.uchicago.edu] |
| Kindler HL, Belani CP, Herndon JE 2nd, Vogelzang NJ, Suzuki Y, Green MR. Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B. Cancer. 1999 Nov 15;86(10):1985-91. Pubmed 10570422 Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, Illinois, USA. |
| Vogelzang NJ, Herndon JE 2nd, Miller A, Strauss G, Clamon G, Stewart FM, Aisner J, Lyss A, Cooper MR, Suzuki Y, Green MR. High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234. Ann Oncol. 1999 May;10(5):597-600. Pubmed 10416012 University of Chicago, Department of Medicine, IL, USA. [mcis.bsd.uchicago.edu] |
| Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest. 1998 Mar;113(3):723-31. Pubmed 9515850 CALGB Statistical Center, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA. [ccstat.mc.duke.edu] |
| Samuels BL, Herndon JE 2nd, Harmon DC, Carey R, Aisner J, Corson JM, Suzuki Y, Green MR, Vogelzang NJ. Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. Cancer. 1998 Apr 15;82(8):1578-84. Pubmed 9554537 Lutheran General Hospital, Park Ridge, Illinois 60068, USA. |
| Yogelzang NJ, Herndon JE 2nd, Cirrincione C, Harmon DC, Antman KH, Corson JM, Suzuki Y, Citron ML, Green MR. Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B. Cancer. 1997 Jun 1;79(11):2237-42. Pubmed 9179072 Section of Hematolog/Oncology, University of Chicago Medical Center, Illinois 60637-1470, USA. |
| Shimada S, Ono K, Suzuki Y, Mori N. Malignant mesothelioma of the tunica vaginalis testis: a case with a predominant sarcomatous component. Pathol Int. 2004 Dec;54(12):930-4. Pubmed 15598316 Department of Pathology of Biological Response, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan. [med.nagoya-u.ac.jp] |
| Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann N Y Acad Sci. 2002 Dec;982:160-76. Pubmed 12562635 Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. [mssm.edu] |
| Kitamura F, Araki S, Suzuki Y, Yokoyama K, Tanigawa T, Iwasaki R. Assessment of the mutations of p53 suppressor gene and Ha- and Ki-ras oncogenes in malignant mesothelioma in relation to asbestos exposure: a study of 12 American patients. Ind Health. 2002 Apr;40(2):175-81. Pubmed 12064559 Department of Public Health and Occupational Medicine, Graduate School of Medicine, The University of Tokyo, Japan. |
| Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Ind Health. 2001 Apr;39(2):150-60. Pubmed 11341545 Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York, USA. |
| Suzuki Y. Pathology of human malignant mesothelioma–preliminary analysis of 1,517 mesothelioma cases. Ind Health. 2001 Apr;39(2):183-5. Pubmed 11341549 Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York, 10029, USA. |
| Moriuchi E, Suzuki Y, Ichikawa Y, Iino S, Kojima H, Abe M. [Long-time survival of a patient with malignant pleural mesothelioma with infiltration of many plasmocytes as a unique feature] Nippon Naika Gakkai Zasshi. 1999 Aug 10;88(8):1530-2. Pubmed 10475019 No address listed. |
| Ito H, Imada T, Kondo J, Amano T, Maehara T, Rino Y, Takahashi M, Shiozawa M, Hatori S, Suzuki Y. A case of malignant peritoneal mesothelioma showed complete remission with chemotherapy. Jpn J Clin Oncol. 1998 Feb;28(2):145-8. Pubmed 9544832 First Department of Surgery, Yokohama City University, School of Medicine, Kanagawa, Japan. |
